In this episode of The Hanley Effect, hosts John Dyben and Dr. Rachel Docekal welcome two leaders in the field of neuroscience and behavioral health: Dr. Antonello Bonci, Founder & Chief Scientific Officer of GIA Healthcare, and Terry Shapiro, Co-CEO and Partner of GIA Healthcare.
Together, they discuss the promise of Transcranial Magnetic Stimulation (TMS), a groundbreaking, non-invasive treatment that uses electromagnetic fields to help rebalance brain activity. TMS has shown remarkable results for people struggling with treatment-resistant depression, OCD, PTSD, and addictions.
Dr. Bonci, a world-renowned neuroscientist and former Scientific Director at the National Institute on Drug Abuse (NIDA), shares the science behind TMS and how decades of research led to its approval in Europe for treating cocaine addiction. Shapiro, a veteran in the behavioral health field since 1986, explains how GIA Healthcare is making TMS accessible to patients across the U.S., while also integrating it with therapy and holistic approaches for the best outcomes.
Listeners will hear about:
- How TMS works and why it’s different from traditional medications.
- The growing evidence of its effectiveness for addiction, mood disorders, insomnia, OCD, and more.
- Who is a good candidate for TMS, and who isn’t.
- Real patient success stories, including individuals who found hope after years of struggling with depression and addiction.
- The vision for making TMS more widely available to those in need.
This conversation is both deeply scientific and full of hope—showing how innovation can change lives when paired with compassionate care.
Learn more about GIA Healthcare at giahealthcare.com
Powered by RedCircle
